Eva R. Trösken

Comparative Assessment of the Inhibition of Recombinant Human CYP19 (Aromatase) by Azoles Used in Agriculture and as Drugs for Humans

Eva R. Trösken, Karoline Scholz, Roman Lutz et al. · Endocrine Research · 2004 · 124 citations

Comparison of lanosterol-14α-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles

Eva R. Trösken, Magdalena Adamska, Michael Arand et al. · Toxicology · 2006 · 89 citations

Antifungal Agent, Antifungal Agents, Candida Albicans +8

Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC–MS/MS method for the analysis of estradiol product formation

Eva R. Trösken, Kathrin H. Fischer, Wolfgang Völkel et al. · Toxicology · 2005 · 83 citations

Estradiol Product Formation, Pharmaceutical Science, Antifungal Agent +8

Quantitation of 13 azole fungicides in wine samples by liquid chromatography–tandem mass spectrometry

Eva R. Trösken, Nataly Bittner, Wolfgang Völkel · Journal of Chromatography A · 2005 · 62 citations

Food Chemistry, Pesticide-residue Analysis, Medicine +8

Quantitation of lanosterol and its major metabolite FF-MAS in an inhibition assay of CYP51 by azoles with atmospheric pressure photoionization based LC-MS/MS

Eva R. Trösken, Ellen Straube, Werner K. Lutz et al. · Journal of the American Society for Mass Spectrometry · 2004 · 59 citations

Pharmaceutical Chemistry, Steroid Balance, Bioanalysis +16